Frederica Di Nicolantonio, Pharm.D., Ph.D., research fellow, Laboratory of Molecular Genetics, The Institute for Cancer Research and Treatment, University of Turin Medical School, speaking at AACR 2009, Denver: BRAF, PIK3CA and KRAS Mutations and Loss of PTEN Expression Impair Response to EGFR-Targeted Therapies in Metastatic Colorectal Cancer
Link to this comment:
All Comments (0)